Thoughts and information about the latest news in the world of migraine, cluster headache and other headache treatment around the world.
Posts tagged as:
Research on the Cox-2 class of drugs continues. Researchers at the University of Pennsylvania School of Medicine studied the effect of Cox-2s on the wall of blood vessels. There is a fatty acid that comes from Cox2s called prostacyclin, which controls the response of the muscular wall of blood vessels. When that fatty acid is [...]
{ 0 comments }
If you’re still trying to sort through the Cox-2 maze, you’re not alone. What’s safe to take and what isn’t? What’s worth the risk? Are there alternatives? What should I take for what? There’s a good overview of the current situation in the USA by Dr Eric Matteson, a Mayo Clinic specialist. Even if you [...]
{ 0 comments }
I hate to bring up the topic of Cox-2 inhibitors one more time, but I did want to let you know in brief what has been happening. In various places in the world, the judgment has been much the same. For example, Europe and the USA seem to be both deciding to allow Cox-2 inhibitors [...]
{ 0 comments }
Cox-2 inhibitors continue to be at the forefront of the news, partly because of the huge economic impact that pulling them will have on some drug companies, partly because of the impact it will have on patients (they were generally prescribed for arthritis, but sometimes for headache), and partly because of the chance it gives [...]
{ 0 comments }
News in the Cox-2 category is still heating up. These were mainly arthritis drugs, although they were being prescribed in some cases for migraine or other types of pain. Vioxx was the first to get pulled, and now other Cox-2 drugs are under the microscope. Now that they’re getting so much attention, more studies are [...]
{ 0 comments }
Loading ...
